Your browser doesn't support javascript.
loading
Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study.
Kannan, Kavya K; Vellanki, Paz; Isom, Scott; Tawfik, Bernard; Winter, Allison; Klepin, Heidi D; Ellis, Leslie R; Bhave, Rupali Roy; Howard, Dianna; Manuel, Megan; Dralle, Sarah; Lyerly, Susan; Powell, Bayard L; Pardee, Timothy S.
Afiliação
  • Kannan KK; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Vellanki P; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
  • Isom S; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA; Department of Biostatistics and Data Science, Wake Forest Baptist Health, USA.
  • Tawfik B; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Winter A; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Klepin HD; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Ellis LR; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Bhave RR; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Howard D; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Manuel M; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Dralle S; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Lyerly S; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Powell BL; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA.
  • Pardee TS; Department of Internal Medicine, Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA; Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest Baptist Health, USA. Electronic address: tspardee@wakehealth.edu.
Leuk Res ; 111: 106731, 2021 12.
Article em En | MEDLINE | ID: mdl-34695644
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Crise Blástica / Quimioterapia de Indução Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Crise Blástica / Quimioterapia de Indução Idioma: En Ano de publicação: 2021 Tipo de documento: Article